“Hydronidone for the Treatment of Liver Fibrosis Related to Chronic Hepatitis B: A Phase 2 Randomized Controlled Trial” Awarded "China's Top 10 Original Research on Portal Hypertension and Cirrhosis"
2023-08-17
On May 24, 2023, the conference review of the "Top 10 Original Research on Portal Hyperten...
First Subject Enrolled for Phase II Clinical Trial of F573 for Injection March 27, 2023, Beijing
2023-03-27
The first subject of phase II clinical trial of F573 for Injection, a new (original) chemi...
《Hydronidone for the treatment of liver fibrosis related to chronic hepatitis B: a Phase 2 randomized controlled trial》will be published in Clinical Gastroenterology and Hepatology
2022-07-14
The paper《Hydronidone for the treatment of liver fibrosis related to chronic hepatitis B:...